{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:48:44Z","timestamp":1747162124880,"version":"3.40.5"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijcrp.2024.200307","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T08:01:28Z","timestamp":1720080088000},"page":"200307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Distinct circulating cytokine levels in patients with angiography-proven coronary artery disease compared to disease-free controls"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9138-0827","authenticated-orcid":false,"given":"Eveliina","family":"Maaniitty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Sinisilta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juho","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuija","family":"Vasankari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Biancari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E. Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Hollm\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomas","family":"Kiviniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2024.200307_bib1","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2024.200307_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad583","article-title":"Economic burden of cardiovascular diseases in the European Union: a population-based cost study","author":"Luengo-Fernandez","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2024.200307_bib3","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","author":"Magnussen","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2024.200307_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","article-title":"Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets","volume":"26","author":"Ramji","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"year":"2000","series-title":"Anti-Inflammatory Cytokines","author":"Opal","key":"10.1016\/j.ijcrp.2024.200307_bib5"},{"key":"10.1016\/j.ijcrp.2024.200307_bib6","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200307_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering cytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nature Reviews Bioengineering"},{"key":"10.1016\/j.ijcrp.2024.200307_bib8","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jtcvs.2019.12.114","article-title":"Adverse events and survival with postpericardiotomy syndrome after surgical aortic valve replacement","volume":"160","author":"Lehto","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"year":"2023","series-title":"R: A Language and Environment for Statistical Computing","key":"10.1016\/j.ijcrp.2024.200307_bib9"},{"key":"10.1016\/j.ijcrp.2024.200307_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: the yin and the yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib11","first-page":"27","article-title":"Tumor necrosis factor and anti-tumor necrosis factor therapies","volume":"37","author":"Keystone","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2014.11.013","article-title":"Hepatocyte growth factor: a regulator of inflammation and autoimmunity","volume":"14","author":"Molnarfi","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ijcrp.2024.200307_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1309\/Q3E6KF0QD3U3YL6T","article-title":"Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay","volume":"125","author":"Martins","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib14","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1172\/JCI85782","article-title":"Alternatively activated macrophages determine repair of the infarcted adult murine heart","volume":"126","author":"Shiraishi","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcrp.2024.200307_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-1","article-title":"Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease","volume":"13","author":"Madhumitha","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib16","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2147\/JIR.S326716","article-title":"Platelet mediated inflammation in coronary artery disease with type 2 diabetes patients","volume":"14","author":"Johny","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijcard.2007.12.060","article-title":"Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention","volume":"132","author":"Rudolph","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2015.05.007","article-title":"The paradoxical role of IL-17 in atherosclerosis","volume":"297","author":"Gong","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib20","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-\u03b3 Are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2024.200307_bib21","article-title":"Serum cytokines predict the severity of coronary artery disease without acute myocardial infarction","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ijcrp.2024.200307_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4013685","article-title":"Serum cytokine profile in relation to the severity of coronary artery disease","volume":"2017","author":"Min","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ijcrp.2024.200307_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cvr\/cvv110","article-title":"IL-9 aggravates the development of atherosclerosis in ApoE-\/-mice","volume":"106","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072769","article-title":"Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis","volume":"8","author":"Gregersen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcrp.2024.200307_bib25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2024.200307_bib26","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2147\/JIR.S276982","article-title":"Insights into the role of inflammation in the management of atherosclerosis","volume":"16","author":"Rocha","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.amjcard.2006.11.032","article-title":"Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome","volume":"99","author":"Sukhija","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.10.012","article-title":"Colony stimulating factors (CSFs): complex roles in atherosclerosis","volume":"122","author":"Singhal","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.ijcrp.2024.200307_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00011-020-01382-6","article-title":"The role of interferon-\u03b3 in cardiovascular disease: an update","volume":"69","author":"Elyasi","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00011-022-01611-0","article-title":"Cytokine storm: behind the scenes of the collateral circulation after acute myocardial infarction","volume":"71","author":"He","year":"2022","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2017.06.001","article-title":"Granulocyte colony-stimulating factor for the treatment of cardiovascular diseases: an update with a critical appraisal","volume":"127","author":"D'Amario","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tcm.2013.06.003","article-title":"Atherosclerosis and interferon-\u03b3: new insights and therapeutic targets","volume":"24","author":"Voloshyna","year":"2014","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ijcrp.2024.200307_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1357343","article-title":"Interferons and interferon-related pathways in heart disease","volume":"11","author":"Tran","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ijcrp.2024.200307_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","author":"Frosteg\u00e5rd","year":"1999","journal-title":"Atherosclerosis 145"},{"key":"10.1016\/j.ijcrp.2024.200307_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.05.066","article-title":"Proinflammatory cytokine IFN-\u03b3, lncRNA BANCR and the occurrence of coronary artery disease","volume":"231","author":"Wang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ijcrp.2024.200307_bib36","first-page":"1339","article-title":"Serum levels and clinical significance of IFN-g and IL-10 in patients with coronary heart disease - liang","volume":"20","author":"Liang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijcrp.2024.200307_bib37","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/hc4201.097835","article-title":"Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease A Randomized, Double-Blind, Placebo-Controlled Study","volume":"104","author":"Seiler","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2024.200307_bib38","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jacc.2005.01.068","article-title":"Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease","volume":"46","author":"Zbinden","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib39","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/CIRCULATIONAHA.106.665570","article-title":"Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice","volume":"115","author":"Haghighat","year":"2007","journal-title":"Circulation"},{"year":"1999","series-title":"Granulocyte-Macrophage Colony-Stimulating Factor Prevents the Progression of Atherosclerosis via Changes in the Cellular and Extracellular Composition of Atherosclerotic Lesions in Watanabe Heritable Hyperlipidemic Rabbits","author":"Shindo","key":"10.1016\/j.ijcrp.2024.200307_bib40"},{"key":"10.1016\/j.ijcrp.2024.200307_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2018.04.067","article-title":"Blood CSF1 and CXCL12 as causal mediators of coronary artery disease","volume":"72","author":"Sjaarda","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2014.10.094","article-title":"Plasma stromal cell-derived factor 1\u03b1\/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease","volume":"238","author":"Ghasemzadeh","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcrp.2024.200307_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cvr\/cvx203","article-title":"Therapeutic strategies utilizing SDF-1\u03b1 in ischaemic cardiomyopathy","volume":"114","author":"Ziff","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijcard.2017.02.011","article-title":"Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion","volume":"233","author":"Tavakolian Ferdousie","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib45","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2024.200307_bib46","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2024.200307_bib47","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2024.200307_bib48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2024.200307_bib49","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1177\/2047487317720287","article-title":"Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors","volume":"24","author":"Vernon","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcrp.2024.200307_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.amjcard.2023.06.045","article-title":"Characteristics and outcomes of young patients with ST-elevation myocardial infarction without standard modifiable risk factors","volume":"202","author":"Kelly","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200307_bib51","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1093\/cvr\/cvab145","article-title":"Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries","volume":"117","author":"Figtree","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcrp.2024.200307_bib52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2024.200307_bib53","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/jc.2016-2081","article-title":"Circulating cytokines predict the development of insulin resistance in a prospective Finnish population cohort","volume":"101","author":"Santalahti","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487524000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487524000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T12:10:20Z","timestamp":1728389420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487524000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":53,"alternative-id":["S2772487524000722"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200307","relation":{},"ISSN":["2772-4875"],"issn-type":[{"type":"print","value":"2772-4875"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct circulating cytokine levels in patients with angiography-proven coronary artery disease compared to disease-free controls","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200307"}}